KAREN SMEDLEY: Open Payments
NPI 1881039717 · SALEM, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 40 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $614 · 2025 $906
Food & beverage: $896Education: $10
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $199 |
| Insmed, Inc. | 1 | $160 |
| ABBVIE INC. | 13 | $148 |
| Madrigal Pharmaceuticals | 1 | $103 |
| Collegium Pharmaceutical, Inc. | 5 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Novo Nordisk Inc | 3 | $48 |
| Lilly USA, LLC | 2 | $32 |
| Exact Sciences Corporation | 1 | $21 |
| Antares Pharma, Inc. | 1 | $17 |
Products named: Arikayce, VRAYLAR, AIRSUPRA, REZDIFFRA, Jornay PM, CAPLYTA, BREZTRI, FARXIGA.
Industry payments across IN — which companies pay providers there.
